HWM
UTHR icon

HB Wealth Management’s United Therapeutics UTHR Stock Holding History

HB Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
2,331
+4
+0.2% +$2.25K 0.01% 644
2026
Q1 		$1.38M Buy
2,327
+321
+16% +$160K 0.01% 540
2025
Q4 		$977K Buy
2,006
+529
+36% +$246K 0.01% 631
2025
Q3 		$619K Buy
1,477
+242
+20% +$81.4K ﹤0.01% 770
2025
Q2 		$355K Buy
1,235
+35
+3% +$10.5K ﹤0.01% 876
2025
Q1 		$370K Buy
1,200
+134
+13% +$45.9K ﹤0.01% 882
2024
Q4 		$376K Buy
+1,066
New +$392K ﹤0.01% 727

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

HB Wealth Management's UTHR Position: Q2 2026 in Review

HB Wealth Management increased its United Therapeutics (UTHR) stake by 0.17% in Q2 2026, buying an estimated $2.25K and bringing the position to 2,331 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #644.

HB Wealth Management first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.38M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • HB Wealth Management held 2,331 shares of United Therapeutics worth $1.26M as of Q2 2026.
  • HB Wealth Management bought 4 United Therapeutics shares in Q2 2026, an estimated $2.25K.
  • United Therapeutics made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #644 holding.
  • HB Wealth Management first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • HB Wealth Management's United Therapeutics position peaked at $1.38M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.